A prospective study on evaluation of maternal and foetal outcomes of hypothyroidism with levothyroxine and prevalence of hypothyroidism in pregnancy in a tertiary care teaching hospital in Kerala
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20200709Keywords:
Hypothyroidism, Prevalence, LevothyroxineAbstract
Background: Pregnancy influences a profound alteration in thyroid function and hypothyroidism has a massive impact on adverse pregnancy outcomes. An appropriate treatment with appropriate dose of levothyroxine is much essential during pregnancy. The present study evaluates the effect of levothyroxine dose in preventing maternal and foetal outcomes and the prevalence of hypothyroidism among pregnant women.
Methods: 1500 antenatal women with singleton gestation attending outpatient of Obstetrics and Gynaecology Department, were analysed. Apart from routine obstetrical investigations, thyroid stimulating hormone (TSH) tests were done at the first antenatal visit. Patients were followed up till delivery after levothyroxine treatment. Their obstetrical and perinatal outcomes were noted. TSH estimation was done 3 days after delivery in new-borns to screen for neonatal thyroid disorders.
Results: The prevalence of hypothyroidism was 10.54%. The common adverse maternal and foetal complications were preeclampsia (15.19%) and low birth weight babies (17.72%) respectively. The mean age of pregnant women was 26.66 years. As age advances there is an increased risk of developing hypothyroidism in pregnancy. Levothyroxine 25 μg daily was highly prescribed in 63.92% hypothyroid patients.
Conclusions: Overall, the prevalence of hypothyroidism was high. Since maternal and foetal complications were higher in patients with hypothyroidism, levothyroxine treatment had decreased the risk of maternal and foetal outcome. Pre-pregnancy screening should be implemented at least in patients with high risk factors for thyroid dysfunction. Universal screening for new-borns is also recommended to detect hypothyroidism. Expert decisions and cost-effectiveness studies will promulgate the impact of universal screening.
References
Akhtar MA, Agrawal R, Brown J, Sajjad Y, Craciunas L. Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism. Cochrane Database Systematic Rev. 2019;25:6:CD011009.
Amudha P, Karthika Devi A, Manochithra B, Delphin Supriya J. Implications of combined endocrinopathy of diabetes mellitus and hypothyroidism on pregnancy. Int J Reprod Contracept Obstetr Gynaecol. 2017;6(1):266-70.
Smallridge RC, Glinoer D, Hollowell JG, Brent G. Thyroid function inside and outside of pregnancy: what do we know and what don’t we know? Thyroid. 2005;15:54-9.
Casey B, Leveno K. Thyroid disease in pregnancy. Obstetr Gynecol. 2006;108(5):1283-92.
Girling J. Thyroid disease in pregnancy. Obstetr Gynaecol Reprod Med. 2008;18:10.
LeBeau SO, Mandel SJ. Thyroid disorders during pregnancy. Endocrinol Metabol Clin North Am. 2006;35:117-36.
Nangia AS, Aggarwal D, Bhatia P, Sharma M, Sarabhai V, Paul M. Prevalence of Overt and Subclinical Thyroid Dysfunction among Pregnant Women and Its Effect on Maternal and Fetal Outcome. J Obstetr Gynaecol India. 2014;64(2):105-10.
Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstetr. 2010;281(2):215-20.
Dhanwal DK, Bajaj S, Rajput R, Subramaniam KA, Chowdhury S, Bhandari R, et al. Prevalence of hypothyroidism in pregnancy: An epidemiological study from 11 cities in 9 states of India. Indian J Endocrinol Metabol. 2016;20:387-90.
Nambiar V, Jagtap VS, Sarathi V, Lila AR, Kamalanathan S, Bandgar TR, et al. Prevalence and Impact of Thyroid Disorders on Maternal Outcome in Asian-Indian Pregnant Women. J Thyroid Res. 2011;2011:429097.
De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol. 2012;97(8):2543-65.
Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081-25.
Dave A, Maru L, Tripathi M. mportance of Universal screening for thyroid disorders in first trimester of pregnancy. Indian J Endocrinol Metabol. 2014;18(5):735-8.
Männistö T. Thyroid Disease During Pregnancy: options for management. Expert Rev Endocrinol Metabol. 2013;8(6):537-47.
Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S, et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding? J Clin Endocrinol Metabol. 2007;92(1):203-7.
Leung AS, Lynne KM, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstetr Gynecol. 1993;81(3):349-52.
Davis LE, Leveno KJ, Cunningham GF. Hypothyroidism complicating pregnancy. Obstetr Gynecol. 1988;72(1):108-13.
Stagnaro GA. Overt Hyperthyroidism and Hypothyroidism during pregnancy. Clin Obstetr Gynecol. 2011;54(3):478-87.
Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12(1):63-8.
Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the First Trimester of Pregnancy. J Clin Endocrinol Metabol. 2010;95(9):44-8.
Cleary Goldman J, Malone FD, Lambert Messerlian G, Sullivan L, Canick J, Porter TF, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstetr Gynecol. 2008;112(1):85-92.
Goel P, Radotra A, Devi K, Malhotra S, Aggarwal A, Huria A. Maternal and perinatal outcome in pregnancy with hypothyroidism. Indian J Med Sci. 2005;59(3):116-7.
Kashi Z, Bahar A, Akha O, Hassanzade S, Esmaeilisaraji L, Hamzehgardeshi Z. Levothyroxine Dosage Requirement During Pregnancy in Well-Controlled Hypothyroid Women: A Longitudinal Study. Global J Health Sci. 2016;8(4):227-33.
Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351(3):241-9.
Hallengren B, Lantz M, Andreasson B, Grennert L. Pregnant women on thyroxine substitution are often dysregulated in early pregnancy. Thyroid. 2009;19(4):391-4.
Kaplan MM. Management of thyroxine therapy during pregnancy. Endocrine Pract. 1996;2(4):281-6.
Mandel SJ. Hypothyroidism and chronic autoimmune thyroiditis in the pregnant state: Maternal aspects. Best Pract Res Clin Endocrinol Metabol. 2004;18(2):213-24.
Pekonen F, Teramo K, Ikonen E, Osterlund K, Makinen T, Lamberg BA. Women on thyroid hormone therapy: pregnancy course, fetal outcome, and amniotic fluid thyroid hormone level. Obstetr Gynecol. 1984;63(5):635-8.
Ain KB, Mori Y, Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metabol. 1987;65(4):689-96.
Huang SA. Physiology and pathophysiology of type 3 deiodinase in humans. Thyroid. 2005;15(8):875-81.
